Larson Financial Group’s Palvella Therapeutics PVLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.1K Hold
73
– – ﹤0.01% 2499
2026
Q2
$11.2K Buy
73
+67
+1,117% +$8.13K ﹤0.01% 2335
2026
Q1
$748 Buy
+6
New +$626 ﹤0.01% 3237

Other funds holding PVLA

Larson Financial Group's PVLA Position: Q3 2026 in Review

Larson Financial Group held its Palvella Therapeutics (PVLA) position steady in Q3 2026 at 73 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2499.

Larson Financial Group first reported a position in PVLA in Q1 2026 and has held it in 3 quarters since. The position peaked at $11.2K in Q2 2026. 196 funds tracked by Wall St. Rank hold PVLA as of Q3 2026.

  • Larson Financial Group held 73 shares of Palvella Therapeutics worth $10.1K as of Q3 2026.
  • Larson Financial Group left its Palvella Therapeutics share count unchanged in Q3 2026.
  • Palvella Therapeutics made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #2499 holding.
  • Larson Financial Group first reported a position in Palvella Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • Larson Financial Group's Palvella Therapeutics position peaked at $11.2K in Q2 2026.
  • 196 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.